Statement on FDA Commissioner Dr. Stephen Hahn by Mary Woolley, Research!America President & CEO

Thursday, December 12, 2019

We applaud the Senate confirmation of Dr. Stephen Hahn as FDA Commissioner. Dr. Hahn is a highly respected radiation oncologist and highly qualified health care leader, as most recently demonstrated by his leadership role at the esteemed MD Anderson Cancer Center. We look forward to supporting Dr. Hahn’s efforts as he takes the helm of this pivotally important public health agency.

Media Contacts

Robert Shalett
Director of Communications 
571-482-2737

Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco